
Prostate Cancer Vaccine Wins US Approval
Note: The cancer vaccine is not a "cure" for prostate cancer. The "vaccine" which harnesses the body's own immune system to fight prostate cancer, has been approved for use by US drug regulators.
Provenge - which is designed to be used in men with advanced disease - is the first of its kind to be accepted by the Food and Drug Administration. Is it an expensive treatment? Each dose has to be individually tailored and it is estimated to cost $93,000 per patient.
It will add to, rather than replace, existing treatments, said experts. Researchers have been working on therapies that prompt the immune system to fight tumors for decades.
Potential success stories include an experimental vaccine for melanoma which is in the late stages of development.
This latest therapy is made by collecting special blood cells from each patient that help the immune system recognize cancer as a threat.
Custom Medical Stock Photo has over 100,000 images on the CMSP.com website available for download and license.
Small files and royalty free images can be viewed and purchase online at CMSP's sister site: www.cmspRF.com
Any questions, contact CMSP at research@cmsp.com









